FDAnews
www.fdanews.com/articles/101212-abbott-8217-s-humira-gets-positive-emea-opinion

Abbott’s Humira Gets Positive EMEA Opinion

November 16, 2007

Abbott Laboratories was given [an] opinion recommending approval of Humira, a treatment for moderate to severe plaque psoriasis, from the Committee for Medicinal Products for Human Use and the scientific committee of the European Medicines Agency.
CNN Money